paris

Dassault Systmes: declaration of the number of outstanding shares and voting rights as of May 31, 2025

Press ReleaseVELIZY-VILLACOUBLAY, France — June 9, 2025                 Declaration of the number of outstanding shares and voting rights as of May…

3 months ago

Beyond the Game: Haier Vision for Youth and Sustainability

PARIS, June 8, 2025 /PRNewswire/ -- In a bold step to advance inclusive growth and engage the younger generation, Haier,…

3 months ago

Open for everyone: Paris 2024 Olympic Aquatics Centre enters legacy mode

06 June 2025 - Less than a year after hosting Olympic and Paralympic competitions, the Olympic Aquatics Centre has recently re-opened…

3 months ago

Haier’s Strategic Partnership with Roland-Garros Enters Third Year, Driving Shared Values of Excellence

PARIS, June 6, 2025 /PRNewswire/ -- As the 2025 Roland-Garros (French Open) enters its final stretch, the iconic clay courts…

3 months ago

HIMSS Unites Global Healthcare Leaders to Shape the Future of Care: From Paris to Kuala Lumpur to Las Vegas

ROTTERDAM, Netherlands, June 6, 2025 /PRNewswire/ -- Thousands of health and technology leaders will gather to share critical health technology…

3 months ago

AI Takes Center Court, Infosys and FFT Unveil Innovative Fan Features for Roland-Garros 2025

Leverage Gen AI and agentic AI to deliver new fan experiences including enhanced and personalized match analysis and creative content…

3 months ago

AI and Sustainability: Akkodis showcases the future of sustainable and digital innovation at the Paris Air Show 2025

The Smart Industry leader supports major companies in the aviation, aerospace and defense industry with digital transformation and invites visitors…

3 months ago

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today…

3 months ago

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…

3 months ago